Stephane R. B. Heymans
#149,314
Most Influential Person Now
Stephane R. B. Heymans's AcademicInfluence.com Rankings
Stephane R. B. Heymansmedical Degrees
Medical
#2852
World Rank
#3294
Historical Rank
Cardiology
#275
World Rank
#281
Historical Rank
Download Badge
Medical Biology
Stephane R. B. Heymans's Degrees
- PhD Cardiovascular Biology University of Antwerp
Why Is Stephane R. B. Heymans Influential?
(Suggest an Edit or Addition)Stephane R. B. Heymans's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. (2021) (2883)
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. (2007) (2589)
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. (2013) (2213)
- Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration (2001) (1032)
- Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure (1999) (843)
- miR-133 and miR-30 Regulate Connective Tissue Growth Factor: Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling (2009) (810)
- Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease (2010) (749)
- Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. (2016) (691)
- Myocarditis and inflammatory cardiomyopathy: current evidence and future directions (2020) (398)
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology (2011) (380)
- Acute viral myocarditis (2008) (355)
- Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology (2009) (319)
- Long noncoding RNAs in cardiac development and ageing (2015) (285)
- Increased Cardiac Expression of Tissue Inhibitor of Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-2 Is Related to Cardiac Fibrosis and Dysfunction in the Chronic Pressure-Overloaded Human Heart (2005) (279)
- Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. (2006) (258)
- Use of circulating microRNAs to diagnose acute myocardial infarction. (2012) (255)
- Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity (2014) (251)
- Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs (2014) (246)
- Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. (2018) (242)
- Oxidation of CaMKII determines the cardiotoxic effects of aldosterone (2011) (236)
- MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure (2011) (226)
- The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. (2016) (223)
- Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure (2013) (221)
- Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. (2021) (217)
- Cardiac involvement in Churg-Strauss syndrome. (2010) (206)
- CARMEN, a human super enhancer-associated long noncoding RNA controlling cardiac specification, differentiation and homeostasis. (2015) (205)
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2022) (201)
- Matricellular proteins in the heart: possible role during stress and remodeling. (2004) (199)
- Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy (2007) (198)
- Thrombospondin-2 Is Essential for Myocardial Matrix Integrity: Increased Expression Identifies Failure-Prone Cardiac Hypertrophy (2004) (196)
- Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2018) (191)
- Integrating cardiac PIP3 and cAMP signaling through a PKA anchoring function of p110γ. (2011) (187)
- Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction (2009) (182)
- MicroRNA Profiling Identifies MicroRNA-155 as an Adverse Mediator of Cardiac Injury and Dysfunction During Acute Viral Myocarditis (2012) (173)
- The continuous heart failure spectrum: moving beyond an ejection fraction classification. (2019) (170)
- Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy (2019) (165)
- Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC) (2020) (165)
- Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition. (2014) (161)
- Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. (2005) (159)
- Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. (2000) (156)
- Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association–European Society of Cardiology (2018) (155)
- Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology (2019) (155)
- Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice (2012) (142)
- Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure (2013) (140)
- Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease (2017) (140)
- TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'. (2010) (134)
- Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms (2021) (118)
- INCREASED EXPRESSION OF SYNDECAN-1 PROTECTS AGAINST CARDIAC DILATATION AND DYSFUNCTION AFTER MYOCARDIAL INFARCTION.: PH.5 (2005) (117)
- Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias (2018) (115)
- Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding (2020) (114)
- Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination (2018) (114)
- Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential (2015) (110)
- Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. (2015) (109)
- Inhibition of Urokinase-Type Plasminogen Activator or Matrix Metalloproteinases Prevents Cardiac Injury and Dysfunction During Viral Myocarditis (2006) (107)
- MicroRNA-221/222 Family Counteracts Myocardial Fibrosis in Pressure Overload–Induced Heart Failure (2018) (107)
- Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases (2021) (106)
- Replacement of the Muscle-Specific Sarcoplasmic Reticulum Ca2+-ATPase Isoform SERCA2a by the Nonmuscle SERCA2b Homologue Causes Mild Concentric Hypertrophy and Impairs Contraction-Relaxation of the Heart (2001) (104)
- Inflammation in viral myocarditis: friend or foe? (2012) (103)
- Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature (2016) (101)
- The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC (2018) (101)
- The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology (2017) (100)
- Cardiac extracellular matrix remodeling: fibrillar collagens and Secreted Protein Acidic and Rich in Cysteine (SPARC). (2010) (98)
- Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy (2009) (96)
- Targeting myocardial remodelling to develop novel therapies for heart failure (2014) (94)
- Treatments targeting inotropy. (2018) (91)
- A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart (2013) (90)
- Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy. (2013) (89)
- Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load (2010) (89)
- Small but smart--microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. (2012) (89)
- The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis. (2015) (87)
- Regulatory RNAs in Heart Failure (2020) (85)
- An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology (2018) (81)
- microRNA-122 down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1 up-regulation. (2014) (80)
- Validation of the HFA‐PEFF score for the diagnosis of heart failure with preserved ejection fraction (2019) (79)
- Prognostic Relevance of Gene-Environment Interactions in Patients With Dilated Cardiomyopathy: Applying the MOGE(S) Classification. (2015) (75)
- Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (2018) (73)
- Advances in Toll-like receptor biology: Modes of activation by diverse stimuli (2015) (71)
- Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy (2010) (69)
- Osteoglycin Prevents Cardiac Dilatation and Dysfunction After Myocardial Infarction Through Infarct Collagen Strengthening (2015) (69)
- Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure (2020) (69)
- The RNA-binding protein HuR (Elavl1) is essential for the B cell antibody response (2015) (67)
- Metabolic support for the heart: complementary therapy for heart failure? (2016) (67)
- miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. (2016) (66)
- Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities (2020) (64)
- Imatinib Attenuates End-Organ Damage in Hypertensive Homozygous TGR(mRen2)27 Rats (2006) (64)
- Syndecan-1 Amplifies Angiotensin II–Induced Cardiac Fibrosis (2010) (64)
- A mutation update for the FLNC gene in myopathies and cardiomyopathies (2020) (63)
- Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. (2015) (61)
- Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (61)
- Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes (2019) (59)
- The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial (2020) (57)
- Immunosuppressive Therapy Improves Both Short- and Long-Term Prognosis in Patients With Virus-Negative Nonfulminant Inflammatory Cardiomyopathy (2018) (57)
- Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells. (2012) (56)
- Regulation of Cardiac Gene Expression by KLF15, a Repressor of Myocardin Activity* (2010) (54)
- Matricellular Signaling Molecule CCN1 Attenuates Experimental Autoimmune Myocarditis by Acting as a Novel Immune Cell Migration Modulator (2010) (54)
- Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity. (2016) (51)
- Sema3A promotes the resolution of cardiac inflammation after myocardial infarction (2017) (50)
- RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection (2015) (49)
- The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease? (2016) (49)
- Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (2018) (48)
- Sex‐specific associations of obesity and N‐terminal pro‐B‐type natriuretic peptide levels in the general population (2018) (47)
- Thrombospondins in the heart: potential functions in cardiac remodeling (2009) (46)
- Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function. (2020) (45)
- Inhibition of MicroRNA-146a and Overexpression of Its Target Dihydrolipoyl Succinyltransferase Protect Against Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction (2017) (45)
- Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure. (2019) (44)
- MicroRNAs are involved in end-organ damage during hypertension. (2012) (44)
- Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial (2020) (43)
- University of Birmingham The RNA-binding protein HuR is essential for the B cell antibody response (2015) (43)
- Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy. (2011) (43)
- Lysosomal integral membrane protein 2 is a novel component of the cardiac intercalated disc and vital for load-induced cardiac myocyte hypertrophy (2007) (42)
- Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives (2016) (42)
- Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies (2012) (42)
- Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice (2016) (41)
- MicroRNAs and beyond: the heart reveals its treasures. (2009) (40)
- STAT3 activity is necessary and sufficient for the development of immune-mediated myocarditis in mice and promotes progression to dilated cardiomyopathy (2013) (39)
- Integrating Cardiac PIP 3 and cAMP Signaling through a PKA Anchoring Function of p 110 g (39)
- Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences (2020) (37)
- Value of Speckle Tracking-Based Deformation Analysis in Screening Relatives of Patients Asymptomatic Dilated Cardiomyopathy. (2020) (36)
- Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation. (2017) (35)
- Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling (2017) (34)
- MicroRNA Involvement in Immune Activation During Heart Failure (2011) (34)
- Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. (2020) (33)
- Clinical Phenotype and Genotype Associations With Improvement in Left Ventricular Function in Dilated Cardiomyopathy (2018) (32)
- Myocarditis and heart failure: need for better diagnostic, predictive, and therapeutic tools. (2007) (32)
- Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF. (2020) (31)
- Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. (2020) (29)
- Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach (2019) (29)
- Colchicine aggravates coxsackievirus B3 infection in mice. (2016) (29)
- Outcome and One Year Follow-up of Intra-arterial Staphylokinase in 191 Patients with Peripheral Arterial Occlusion (2000) (28)
- Interactions between the extracellular matrix and inflammation during viral myocarditis. (2012) (28)
- Ventricular myocarditis coincides with atrial myocarditis in patients. (2014) (27)
- Heart ‘omics’ in AGEing (HOMAGE): design, research objectives and characteristics of the common database (2014) (27)
- Inflammation and cardiac remodeling during viral myocarditis. (2006) (27)
- Matricellular proteins and matrix metalloproteinases mark the inflammatory and fibrotic response in human cardiac allograft rejection (2012) (27)
- Non-coding RNAs in vascular disease – from basic science to clinical applications: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (2018) (26)
- MicroRNAs as Biomarkers for Ischemic Heart Disease (2013) (26)
- Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure (2019) (25)
- Differences in virus prevalence and load in the hearts of patients with chronic dilated cardiomyopathy with and without immune-mediated inflammatory disease (2010) (25)
- Implications of Genetic Testing in Dilated Cardiomyopathy (2020) (25)
- Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy (2021) (25)
- A model-based assay design to reproduce in vivo patterns of acute drug-induced toxicity (2017) (24)
- Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) (24)
- A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis (2016) (23)
- NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis. (2018) (23)
- AntagomiR-103 and -107 Treatment Affects Cardiac Function and Metabolism (2018) (23)
- Propionic acidemia as a cause of adult-onset dilated cardiomyopathy (2017) (23)
- Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis (2017) (22)
- Association of left ventricular mass with the AGTR1 A1166C polymorphism. (2012) (22)
- Selective NADH communication from α-ketoglutarate dehydrogenase to mitochondrial transhydrogenase prevents reactive oxygen species formation under reducing conditions in the heart (2020) (22)
- Heart Failure With Recovered Ejection Fraction. (2018) (21)
- MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock (2018) (20)
- Metabolic Profiling Associates with Disease Severity in Non-Ischemic Dilated Cardiomyopathy. (2020) (20)
- cyNeo4j: connecting Neo4j and Cytoscape (2015) (20)
- Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure) (2020) (19)
- SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis. (2018) (19)
- Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy (2018) (19)
- The HFA‐PEFF and H2FPEF scores largely disagree in classifying patients with suspected heart failure with preserved ejection fraction (2020) (19)
- The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis (2018) (18)
- Network integration and modelling of dynamic drug responses at multi-omics levels (2020) (18)
- Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction (2020) (18)
- Plasma protein biomarkers and their association with mutually exclusive cardiovascular phenotypes: the FIBRO-TARGETS case–control analyses (2019) (18)
- Giant cell myocarditis triggered by a parvovirus B19 infection. (2009) (18)
- Bone marrow transplantation rescues infarct healing, whereas vascular endothelial growth factor fails to increase angiogenesis in urokinase deficient mice after acute myocardial infarction (2000) (18)
- Extracellular SPARC increases cardiomyocyte contraction during health and disease (2019) (17)
- Post‐discharge arrhythmic risk stratification of patients with acute myocarditis and life‐threatening ventricular tachyarrhythmias (2021) (17)
- The combination of PICP blood levels and LGE at CMR provides additional prognostic information in idiopathic Dilated Cardiomyopathy. (2021) (17)
- Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129 (2019) (16)
- Lymphocytic myocarditis occurs with myocardial infarction and coincides with increased inflammation, hemorrhage and instability in coronary artery atherosclerotic plaques. (2017) (16)
- Heart failure with preserved ejection fraction: a nephrologist-directed primer (2017) (15)
- Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 1: overview and the central role for catecholamines and sympathetic nervous system (2021) (15)
- AMPKα1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism (2021) (15)
- Virus Infection of the Heart – Unmet Therapeutic Needs (2012) (15)
- Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy (2010) (15)
- The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy (2021) (14)
- Risk of bias in studies investigating novel diagnostic biomarkers for heart failure with preserved ejection fraction. A systematic review (2020) (14)
- Feasibility Study of Catheter-directed Thrombolysis with Recombinant Staphylokinase in Deep Venous Thrombosis (1998) (14)
- ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models (2014) (14)
- Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy (2022) (13)
- Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis (2020) (13)
- Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis. (2015) (13)
- Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC) (2021) (12)
- Diagnostic approach of myocarditis: strike the golden mean (2014) (12)
- Circulating MicroRNA-208 b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease Running title : (2010) (12)
- Factor XIII: the cement of the heart after myocardial infarction? (2008) (12)
- The HFA-PEFF and the H2 FPEF score largely disagree in classifying suspected HFpEF patients. (2020) (12)
- Left Atrial Strain Has Superior Prognostic Value to Ventricular Function and Delayed-Enhancement in Dilated Cardiomyopathy. (2022) (12)
- Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. (2021) (12)
- CD45 is a more sensitive marker than CD3 to diagnose lymphocytic myocarditis in the endomyocardium. (2017) (11)
- High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men. (2020) (11)
- Intravenous immunoglobulin therapy in adult patients with idiopathic chronic cardiomyopathy and cardiac parvovirus B19 persistence: a prospective, double‐blind, randomized, placebo‐controlled clinical trial (2021) (11)
- Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function (2021) (10)
- Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial (2021) (9)
- Immunometabolic mechanisms of heart failure with preserved ejection fraction (2022) (9)
- Intravenous Immunoglobulin Therapy in Adult Patients with Chronic Idiopathic Cardiomyopathy and Cardiac Parvovirus B19 persistence. (2020) (9)
- Mutations in PDLIM5 are rare in dilated cardiomyopathy but are emerging as potential disease modifiers (2019) (9)
- A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF. (2020) (9)
- Unlocking the Value of White Blood Cells for Heart Failure Diagnosis (2020) (8)
- The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial (2022) (8)
- Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction (2020) (8)
- Correction: A Deep Sequencing Approach to Uncover the miRNOME in the Human Heart (2013) (7)
- Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy (2021) (7)
- Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients (2022) (7)
- Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. (2021) (7)
- The Network Library: a framework to rapidly integrate network biology resources (2016) (7)
- Gene inactivation of U-PA or adenoviral gene transfer of tissue inhibitor of metalloproteinases-1 impedes cardiac hypertrophy and fibrosis, but improves cardiac function during hypertension in mice (2000) (7)
- Fibrosis or hypertrophy: let TIMPs decide. (2014) (7)
- Right ventricular function in dilated cardiomyopathy and ischemic heart disease: assessment with non-invasive imaging (2015) (7)
- Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy. (2022) (6)
- Lymphocytes infiltrate the quadriceps muscle in lymphocytic myocarditis patients: a potential new diagnostic tool. (2014) (6)
- Response to Letter Regarding Article, “Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease” (2011) (5)
- Valproic acid stimulates myogenesis in pluripotent stem cell-derived mesodermal progenitors in a NOTCH-dependent manner (2020) (5)
- Parvovirus B19 in Dilated Cardiomyopathy: There Is More Than Meets the Eye. (2019) (5)
- The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fraction (2021) (5)
- Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data (2022) (5)
- Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization (2021) (5)
- Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial (2021) (5)
- The Missing “lnc” between Genetics and Cardiac Disease (2020) (5)
- Cardiac Inflammation Impedes Response to Cardiac Resynchronization Therapy in Patients with Idiopathic Dilated Cardiomyopathy. (2020) (5)
- Balance of Active, Passive, and Anatomical Cardiac Properties in Doxorubicin-Induced Heart Failure (2019) (5)
- The HFA‐PEFF score identifies ‘early‐HFpEF’ phenogroups associated with distinct biomarker profiles (2022) (4)
- Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis? (2021) (4)
- Distinct Cardiac Transcriptomic Clustering in Titin and Lamin A/C-Associated Dilated Cardiomyopathy Patients. (2020) (4)
- Systems biology cyNeo 4 j : connecting Neo 4 j and Cytoscape (2015) (4)
- Annexin A5 and the failing heart; lost or found in translation? (2007) (4)
- Neutrophil inhibition improves acute inflammation in a murine model of viral myocarditis (2022) (4)
- Identification of sex‐specific biomarkers predicting new‐onset heart failure (2021) (4)
- Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection (2022) (4)
- Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial. (2021) (4)
- Anthracycline-Related Heart Failure: Certain Knowledge and Open Questions (2020) (4)
- Diastolic heart failure after acute myocarditis, a new discovery in inflammatory cardiomyopathies? (2011) (4)
- Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes (2018) (4)
- Thrombospondin 1: a protective "matri-cellular" signal in the stressed heart. (2011) (4)
- Breeding Strategy Determines Rupture Incidence in Post-Infarct Healing WARPing Cardiovascular Research (2015) (4)
- Peroxidasin-like protein: expanding the horizons of matrix biology. (2014) (3)
- Inflammation and heart failure: a two-sample Mendelian randomization study (2022) (3)
- The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model (2020) (3)
- PD-(L)1 Inhibition and Cardiac Damage: A Relevant Toxicity? (2018) (3)
- SARS-CoV-2 infection leads to cardiac pericyte loss, fibrosis, cardiomyocyte hypertrophy, and diastolic dysfunction (2020) (3)
- Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry (2022) (3)
- Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF (2021) (3)
- A global longitudinal strain cut‐off value to predict adverse outcomes in individuals with a normal ejection fraction (2021) (3)
- ANCA-Associated Vasculitis: Microscopic Polyangiitis, Eosinophilic Granulomatosis With Polyangiitis (Churg–Strauss Syndrome) and Granulomatosis With Polyangiitis (Wegener’s Granulomatosis) (2017) (3)
- Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial (2022) (3)
- Scientific updates on the interaction of genes, epigenetics, and multicellularity in cardiovascular diseases: the Working Group of Myocardial Function of the ESC. (2018) (3)
- Stabilin-1 mediates beneficial monocyte recruitment and tolerogenic macrophage programming during CVB3-induced viral myocarditis. (2021) (3)
- Treatments targeting inotropy A position paper of the Committees on Translational Research and Acute Heart Failure of the Heart Failure Association of the European Society of Cardiology (2019) (3)
- Linagliptin prevents left ventricular stiffening by reducing titin cleavage and hypophosphorylation (2020) (3)
- Prednisone and azathioprine in patients with inflammatory cardiomyopathy: systematic review and meta‐analysis (2020) (3)
- Letter by Pinto and Heymans regarding article, "Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice". (2008) (3)
- Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure (2012) (2)
- NOX1 mediates metabolic heart disease in mice and is upregulated in monocytes of humans with diastolic dysfunction (2021) (2)
- Chronic Q fever leads to dilated cardiomyopathy in a 48-year-old male. (2016) (2)
- Cartilage intermediate layer protein 1 (CILP1): A novel mediator of cardiac extracellular matrix remodelling (2017) (2)
- Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research (2010) (2)
- Abstract 11247: The Long Noncoding MALAT1 - MascRNA System is a Novel Regulator of Cardiac Innate Immunity (2014) (2)
- A passionate endurance cyclist ultimately survives sudden death in right ventricular giant cell myocarditis. (2014) (2)
- Sex differences in the longitudinal relationship of low-grade inflammation and echocardiographic measures in the Hoorn and FLEMENGHO Study (2021) (2)
- AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditis (2022) (2)
- Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood (2021) (2)
- INCREASED CARDIAC EXPRESSION OF TIMP-1 AND TIMP-2 IS RELATED TO CARDIAC FIBROSIS AND DYSFUNCTION IN THE CHRONIC PRESSURE-OVERLOADED HUMAN HEART.: PD.7 (2005) (1)
- Abstract 1889: CHIP-based Sequence Analysis of 34 Cardiomyopathy Genes Reveals New Genes Involved in HCM and DCM and Multiple Pathogenic Mutations in Single Patients (2009) (1)
- P.026 A PIVOTAL ROLE OF THE ANTI-ANGIOGENETIC FACTOR THROMBOSPONDIN-2 IN THE PROGRESSION OF CARDIAC HYPERTROPHY TO FAILURE (2006) (1)
- Dynamic Ejection Fraction Trajectory in Patients With Dilated Cardiomyopathy With a Truncating Titin Variant. (2022) (1)
- Cardiomyocyte disintegration during Anderson-Fabry's disease. (2010) (1)
- 297Osteoglycin regulates cardiac fibrosis in the pressure-overloaded heart (2014) (1)
- Matrix protein Osteonectin (SPARC) reduces inflammation and mortality during viral myocarditis (2013) (1)
- Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial (2022) (1)
- Cardiac involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegeners) (2013) (1)
- Left Atrial Reverse Remodeling in Dilated Cardiomyopathy. (2022) (1)
- Mimecan is an essential regulator of extracellular matrix integrity after myocardial infarction (2010) (1)
- Interatrial Block Predicts Life‐Threatening Arrhythmias in Dilated Cardiomyopathy (2022) (1)
- ICD Implantation in Patients with Nonischemic Heart Failure. (2017) (1)
- Abstract 1369: Endothelial-Specific Overexpression of Nox2 Enhances Angiotensin II-Induced Cardiac Dysfunction and Fibrosis (2008) (1)
- LifeTime and improving European healthcare through cell-based interceptive medicine (2020) (1)
- Chapter 13 – Small but Smart: microRNAs in the Center of Inflammatory Processes During Cardiovascular Diseases, the Metabolic Syndrome, and Aging* (2015) (1)
- Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank (2022) (1)
- Osteoglycin increases cardiac inflammation by enhancing toll-like receptor 4 activation (2015) (1)
- CD40‐CD40 ligand (CD40L) signaling modulates cardiac hypertrophy in angiotensin‐II induced hypertensive heart disease (2013) (1)
- MicroRNA-146a interferes with TCA cycle flux via DLST and rewires cardiomyocyte metabolism in hypertensive heart failure (2014) (1)
- ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGFβ signalling after pressure overload (2022) (1)
- Role of urokinase-type plasminogen activator in ventricular wall rupture, scar formation, and cardiac function after myocardial infarction (1999) (1)
- The Heart Reveals Its Treasures (2009) (1)
- High blood pressure, low ejection fraction and shorter symptom duration are the main predictors of improved left ventricular reversed remodelling in patients with idiopathic dilated cardiomyopathy (2014) (1)
- Comprehensive Cardiovascular Magnetic Resonance‐Derived Myocardial Strain Analysis Provides Independent Prognostic Value in Acute Myocarditis (2022) (1)
- A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis (2016) (1)
- Abstract 10960: Genetic Overlap of Acute Myocarditis and Inherited Cardiomyopathy (2021) (1)
- Life-threatening ventricular arrhythmia prediction in patients with dilated cardiomyopathy using explainable electrocardiogram-based deep neural networks (2022) (1)
- Inactivation of the immune receptor CD40 attenuates the development of cardiac hypertrophy in angiotensin-II induced hypertensive heart disease (2013) (1)
- P69The microRNA-221/222 family is differentially regulated in cardiac disease and counteracts pressure overload-induced cardiac remodeling in mice (2014) (1)
- Allele-specific expression analysis for complex genetic phenotypes applied to a unique dilated cardiomyopathy cohort (2023) (1)
- DPP4 inhibition by linagliptin prevents the development of heart failure with preserved ejection fraction in the metabolic syndrome ZSF1 rats (2017) (0)
- P1501Patients who do not respond to cardiac resynchronization therapy show elevated markers of inflammation in endomyocardial biopsies and blood serum (2017) (0)
- Matrix metalloproteinases and plasminogen system are involved in hypertrophic cardiomyopathy due to pressure-overload in human (2003) (0)
- Extracellular SPARC improves cardiomyocyte contraction during health and disease (2018) (0)
- Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. (2022) (0)
- Erratum: Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy (Proceedings of the National Academy of Sciences of the United States of America (2007) 104, (7074-7079) DOI: 10.1073/pnas.0701981104) (2007) (0)
- Perimyocarditis Complicated by Early Development of Constrictive Pericarditis. (2016) (0)
- Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial). (2023) (0)
- Osteoglycin (OGN) modulates inflammation during viral myocarditis via an interaction with Toll Like Receptor 4. (2013) (0)
- Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19 (2022) (0)
- Prevalence and Clinical Consequences of Multiple Pathogenic Variants in Dilated Cardiomyopathy (2023) (0)
- Focal myocardial fibrosis detected with magnetic resonance late Gadolinium enhancement imaging and diffuse interstitial fibrosis determined with histological staining of endomyocardial biopsy specimens in patients with non-ischemic left ventricular systolic dysfunction: two distinct entities? (2009) (0)
- MicroRNA-221/-222 amends protective mechanisms in CVB3-induced murine myocarditis (2014) (0)
- Stabilin-1 mediated monocyte adhesion protects against adverse cardiac inflammation during viral myocarditis (2013) (0)
- Role of SPARC in Cardiac Extracellular Matrix Remodeling After Myocardial Infarction (2013) (0)
- Abstract 208: Down Regulation of the Novel Transcriptional Regulator of Cardiac Hypertrophy, Kruppel-Like Factor 15, is Mediated by TGF-Beta Induced p38 Activation in vivo and in vitro. (2006) (0)
- P.025 ABSENCE OF SYNDECAN-1 RESULTS IN INCREASED INFARCT HEALING AND DEPRESSED CARDIAC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION (2006) (0)
- Abstract 902: Lysosomal Integral Membrane Protein-2 is a Novel Component of the Intercalated Disc and Essential for a Compensatory Hypertrophic Response to Pressure-Overload (2006) (0)
- Abstract 13606: Patients With Lymphocytic Myocarditis Have Increased Lymphocytes in the Skeletal Muscle: A New Diagnostic Tool (2013) (0)
- Vision Core Leuven: a service platform for compound screening and disease modelling (2016) (0)
- The microRNA 221/222 cluster controls CVB3-induced myocarditis: could tiny microRNAs explain adverse inflammation in the heart? (2013) (0)
- 112 Thrombospondin‐2 guards against aging‐related cardiomyopathy by increasing beta 1‐integrin mediated signaling (2008) (0)
- Bringing biological networks to the desk: combine and analyse with neo4j and cytoscape (2014) (0)
- Patients With Lymphocytic Myocarditis Have Increased Lymphocytes in the Skeletal Muscle: A New Diagnostic Tool (2013) (0)
- Matrix metalloproteinases-1 and -9, new biomarkers of human cardiac allograft rejection (2008) (0)
- Publisher Correction: LifeTime and improving European healthcare through cell-based interceptive medicine (2021) (0)
- Response to 'The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes'. (2020) (0)
- SARS-CoV-2 infection causes prolonged cardiomyocyte swelling and inhibition of HIF1α translocation in an animal model COVID-19 (2022) (0)
- u-PA-Gene Inactivation or TIMP-1-Gene Transfer Impairs Cardiac Injury Caused by Viral Myocarditis in Mice (2002) (0)
- Abstract 202: Thrombospondin-2 Protects Against Uncontrolled Cardiac Inflammation and Oxidative Stress During Doxorubicin-Induced Myocarditis (2006) (0)
- 8 Ventricular myocarditis coincides with atrial myocarditis in humans * (2015) (0)
- MiR-21 mediates interstitial fibrosis in cardiac allograft by supporting monocyte to fibroblast transition (2013) (0)
- Winter Meeting on Translational Heart Failure Research of the European Society of Cardiology Heart Failure Association (2013) (0)
- 283 u‐PA‐inactivation or TIMP‐1‐overexpression prevents cardiac injury and dysfunction during acute viral myocarditis in mice (2004) (0)
- Angiotensin II-induced cardiac fibrosis and diastolic dysfunction in transgenic mice with endothelial-targeted overexpression of Nox2 (2008) (0)
- Thrombospondin-2 acts as a soldier against age-related cardiomyopathy (2006) (0)
- Obesity-related reduction in NT-proBNP levels in healthy individuals is greater in women compared to men (2018) (0)
- The matricellular proteins thrombospondin‐2, osteonectin and osteoglycin modulate cardiac inflammation, injury and function during viral myocarditis. (2012) (0)
- Retrospective assessment of immunosuppressive agents in virus-negative inflammatory cardiomyopathy (2015) (0)
- Aldosterone Enhances Cardiac Rupture After Myocardial Infarction Through Calcium/Calmodulin-Dependent Protein Kinase II (2011) (0)
- Abstract 81: Absence of Macrophage microRNA-155 Affects Cardiac Metabolic and Inflammatory Remodeling Following Diabesotension and Protects Against Development of Heart Failure (2016) (0)
- Reply to the letter to the editor "Is colchicine really harmful in viral myocarditis?" (2017) (0)
- Prognostic relevance of gene-environment interactions in dilated cardiomyopathy patients: applying the MOGES classification (2015) (0)
- MULTI-PARAMETRIC PHENOMAPPING USING MACHINE LEARNING IDENTIFIES A NOVEL SUBTYPE OF DILATED CARDIOMYOPATHY AND HIGHLIGHTS IL4R AS A NOVEL PROGNOSTIC BIOMARKER (2021) (0)
- 522 Increased expression of syndecan‐1 protects against cardiac dilatation and dysfunction after myocardial infarction (2006) (0)
- Schroen and Heymans MicroRNAs in Hypertensive Heart Disease 1191 (2009) (0)
- Myocarditis and pericarditis (2021) (0)
- The effect of spironolactone in patients with obesity at risk for heart failure: proteomic insights from the HOMAGE trial (2021) (0)
- Replacement of SERCA2a with the non-muscle SERCA2b isoform in transgenic mice (2000) (0)
- Absence of microRNA‐155 protects against pressure overload‐induced cardiac inflammation and failure (2012) (0)
- Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: infarction. Commentary : implications for FXIII therapy and antithrombin use in myocardial (2008) (0)
- Micro-RNA 146a: a new kid on the block in the pathophysiology of cardiac hypertrophy and hypertensive heart failure, and a promising therapeutic target (2012) (0)
- P123DPP-4 inhibition by Linagliptin prevents cardiac inflammation, fibrosis, hypertrophy, and stiffness in obese ZSF1 rats (2018) (0)
- The extracellular matrix SPARCs cardiac contraction during health and disease (2016) (0)
- Heart valve tissue-engineered matrices attenuate monocyte binding and procoagulant responses in human endothelial cell cultures exposed to S. aureus, S. sanguis and S. epidermidis (2012) (0)
- CMR-derived left ventricular intraventricular pressure gradients identify different patterns associated with prognosis in dilated cardiomyopathy. (2023) (0)
- Abstract 10161: Predicting Life-Threatening Ventricular Arrhythmias in Patients with Non-Ischemic Dilated Cardiomyopathy Using Electrocardiogram-Based Deep Neural Networks (2021) (0)
- 84 Left atrial reverse remodelling in dilated cardiomyopathy (2021) (0)
- Stabilin‐1 protects against adverse inflammation and injury during viral myocarditis (2012) (0)
- University of Birmingham Extracellular SPARC increases cardiomyocyte contraction during health and disease (2019) (0)
- 485 Inhibition of urokinase and matrix metalloproteinases prevents left ventricular hypertrophy and cardiac failure during hypertension (2004) (0)
- Abstract 898: The Kruppel-Like Factor KLF15 is a Novel Regulator of Cardiomyocyte Hypertrophy (2006) (0)
- Absence of micro-RNA 146a blunts the hypertrophic response upon cardiac pressure overload (2011) (0)
- MicroRNA profiling in humans and mice identifies microRNA-155 as a key regulator of acute cardiac allograft rejection (2014) (0)
- Mimecan promotes wound healing after myocardial infarction (2012) (0)
- Abstract 16544: Focal Fibrosis Predicts Monomorphic VT but Not Polymorphic VT or VF in Nonischemic Dilated Cardiomyopathy (2014) (0)
- Clustering of Cardiac Transcriptome Profiles Reveals Unique (2023) (0)
- Cardias TIMP-1 and TIMP-2 expression: markers of interstitial fibrosis in patients with aortic stenosis (2004) (0)
- Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction Heart Failure (2007) (0)
- MicroRNA-155 has a pivotal role in acute cardiac allograft rejection (2011) (0)
- Osteonectin protects against adverse cardiac inflammation during viral myocarditis (2013) (0)
- Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity (2023) (0)
- Heggermont and Heymans MicroRNAs in Hypertension and Target Organ Damage 3 Kidney : Renal Fibrosis and Hypertensive Kidney Failure (0)
- Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial (2022) (0)
- Abstract 12091: Aldosterone Enhances Cardiac Rupture After Myocardial Infarction Through Calcium/Calmodulin-Dependent Protein Kinase II (2011) (0)
- MicroRNA-155 promotes acute cardiac allograft rejection in human and mice (2013) (0)
- 545MiR-139 expression is detrimental during pressure overload-induced heart failure (2014) (0)
- Inhibition of proteinases prevents cardiac injury during viral myocarditis (2004) (0)
- Inflammation and Syndecan-4 Shedding from Cardiac Cells in Ischemic and Non-Ischemic Heart Disease (2023) (0)
- Left Atrial Strain Is an Independent Predictor of New-Onset Atrial Fibrillation in Dilated Cardiomyopathy. (2023) (0)
- A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial. (2023) (0)
- Abstract 310: Thrombospondin 2 Protects Against Uncontrolled Cardiac Inflammation and Injury During Viral Myocarditis (2008) (0)
- OP4-4 Prevalence, quantification and cut-off level of parvovirus B19 DNA in endomyocardial biopsies of cardiac patients and non-cardiac control subjects (2009) (0)
- 1090 Hypertension November 2012 Kidney : Renal Fibrosis and Hypertensive Kidney Failure Studies in Models of Arterial Hypertension (0)
- Sex-specific associations of body composition measures with cardiac function and structure after 8 years of follow-up (2021) (0)
- Functional Screening Identifies MicroRNAs as Multi-Cellular Regulators of Heart Failure (2019) (0)
- Role of Inflammation and Matrix Proteinases in Cardiac Remodeling Following Stress and Injury (2013) (0)
- Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity (2022) (0)
- Resistance to retinopathy development in obese, diabetic and hypertensive ZSF1 rats: an exciting model to identify protective genes (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Stephane R. B. Heymans?
Stephane R. B. Heymans is affiliated with the following schools:
